NCT05494788 - Impact of CardiolRxTM on Recurrent Pericarditis (MAvERIC-Pilot) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 9, 2023

Primary Completion Date

June 15, 2024

Study Completion Date

September 6, 2024

Conditions

Recurrent Pericarditis

Interventions

DRUG

CardiolRx

Oral solution

Trial Locations (8)

MedStar Health Research Institute, Washington D.C.

Virginia Commonwealth University Health, Richmond

Cleveland Clinic, Cleveland

Minneapolis Heart Institute Foundation, Minneapolis

Mayo Clinic, Rochester

Pima Heart and Vascular Clinical Research, Tucson

Massachusetts General Hospital, Boston

University of Vermont Medical Center, Burlington